• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Lotte Bio launch­es ADC ser­vices; Yp­somed to fo­cus on self-in­jec­tion busi­ness

3 weeks ago
Manufacturing

Avidi­cure's $50M seed round; Flag­ship's new AI com­pa­ny that de­tects dis­ease

3 weeks ago
News Briefing

Ver­san­t's lat­est biotech fo­cus­es on in­flam­ma­to­ry dis­eases

3 weeks ago
Financing
Startups

Bris­tol My­er­s' tran­si­tion moves for­ward as it rais­es 2025 rev­enue fore­cast

3 weeks ago
Pharma

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

3 weeks ago
China
Pharma

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

3 weeks ago
Pharma

Mer­ck’s Gar­dasil sales sink fur­ther amid Chi­na mar­ket pres­sure

3 weeks ago
China
Pharma

Sanofi's Al­tuvi­i­io clos­ing in on block­buster sta­tus, Dupix­ent sales surge

3 weeks ago
R&D
Pharma

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

3 weeks ago
Deals
Pharma

As­traZeneca CEO says Eu­rope is 'falling be­hind' on R&D and man­u­fac­tur­ing in­vest­ments

3 weeks ago
People
Pharma

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

3 weeks ago
Pharma
FDA+

Top phar­ma com­pa­nies in­creased lob­by­ing spend in first quar­ter of 2025

3 weeks ago
Pharma
FDA+

Ve­r­axa makes a SPAC deal; Il­lu­mi­na dis­clos­es lay­offs

3 weeks ago
News Briefing

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

3 weeks ago
Deals
China

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

3 weeks ago
People
Pharma

FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval

3 weeks ago
Pharma
FDA+

Te­lenu­tri­tion start­up Nour­ish rais­es $70M

3 weeks ago
Health Tech

Genen­tech vet launch­es ADC start­up with $20M

3 weeks ago
Financing
Startups

As­cle­tis posts puz­zling Phase 1 up­date on obe­si­ty pill

3 weeks ago
R&D

Ake­so re­ports an­oth­er Phase 3 win for PD-1xVEGF ap­proach in lung can­cer

3 weeks ago
R&D

Reper­toire inks au­toim­mune deal with Genen­tech as it eyes a re­turn to the clin­ic

3 weeks ago
Startups
Deals

Ex­clu­sive: Chica­go start­up Grove Bio­phar­ma nabs $30M Se­ries A

3 weeks ago
Financing
Startups

Eli Lil­ly sues four tele­health com­pa­nies sell­ing com­pound­ed tirzepatide

3 weeks ago
Pharma
Law

Boehringer taps Dutch biotech for ALT pos­i­tive can­cer pact ex­ceed­ing $573M in biobucks

3 weeks ago
Deals
R&D
First page Previous page 567891011 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times